EnVVeno Medical Corporation (NASDAQ:NVNO) | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

BRIEF

published on 11/20/2024 at 14:35, 19 hours 23 minutes ago

EnVVeno Medical dévoile les résultats de l'essai VenoValve sur un an

Essai Clinique Valve VenoValve Traitement CVI Demande D'admission À La FDA Résultats En Matière De Santé
BRIEF

published on 11/20/2024 at 14:35, 19 hours 23 minutes ago

EnVVeno Medical Unveils One-Year VenoValve Trial Results

Clinical Trial VenoValve Health Outcomes FDA Application CVI Treatment
PRESS RELEASE

published on 11/20/2024 at 14:30, 19 hours 28 minutes ago

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
enVVeno Medical presents one-year data on VenoValve U.S. pivotal trial at VEITH Symposium supporting FDA pre-market authorization application. Study shows significant clinical benefits and safety profile

EnVVeno Medical VenoValve FDA Application Pivotal Trial VEITH Symposium
BRIEF

published on 11/19/2024 at 14:20, 1 day 19 hours ago

EnVVeno Medical demande l'approbation de la FDA pour VenoValve

EnVVeno Medical Insuffisance Veineuse Chronique Approbation De La FDA Valve VenoValve Demande De PMA
BRIEF

published on 11/19/2024 at 14:20, 1 day 19 hours ago

EnVVeno Medical Seeks FDA Approval for VenoValve

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency PMA Application
PRESS RELEASE

published on 11/19/2024 at 14:15, 1 day 19 hours ago

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
enVVeno to present definitive one year data from PMA application at 51st VEITH Symposium. Company aims for FDA approval to market VenoValve in the US

FDA Approval VenoValve CVI PMA Application EnVVeno
BRIEF

published on 10/31/2024 at 13:40, 20 days 20 hours ago

Résultats financiers du troisième trimestre 2024 d'enVVeno Medical et prochaines étapes de la FDA

Résultats Financiers Essais Cliniques Approbation De La FDA Valve VenoValve Progrès EnVVe
BRIEF

published on 10/31/2024 at 13:40, 20 days 20 hours ago

EnVVeno Medical's Q3 2024 Financials and Upcoming FDA Milestones

Financial Results FDA Approval Clinical Trials VenoValve EnVVe Progress
PRESS RELEASE

published on 10/31/2024 at 13:35, 20 days 20 hours ago

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
enVVeno Medical Corporation reports progress towards FDA PMA approval for VenoValve and enVVe transcatheter-based valve replacement. Company ends quarter with $48.4M cash

Financial Results VenoValve Clinical Program FDA PMA Approval EnVVe Transcatheter Valve
BRIEF

published on 10/28/2024 at 13:35, 23 days 20 hours ago

EnVVeno Medical Commences Pre-Clinical Study for enVVe Valve

FDA Approval EnVVeno Medical CVI Treatment GLP Study EnVVe Valve

1 2 ... 7

Accesswire

Published on 11/21/2024 at 09:00, 58 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 23 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 33 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 58 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 58 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 16 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 56 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 58 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 58 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 42 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 50 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 38 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE